{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:40:56Z","timestamp":1791319256743,"version":"4.3.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00520-016-3156-8","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T05:01:27Z","timestamp":1458622887000},"page":"3473-3480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients\u2014Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study"],"prefix":"10.1007","volume":"24","author":[{"given":"Koichi","family":"Takayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Atagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Minato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Katakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Yoshimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Hataji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Aoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hak","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tabeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Tomii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"3156_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1207\/S15327914NC352_5","volume":"35","author":"P O\u2019Gorman","year":"1999","unstructured":"O\u2019Gorman P, McMillan DC, McArdle CS (1999) Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer 35:127\u2013129","journal-title":"Nutr Cancer"},{"key":"3156_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1207\/S15327914NC3701_4","volume":"37","author":"P O\u2019Gorman","year":"2000","unstructured":"O\u2019Gorman P, McMillan DC, McArdle CS (2000) Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37:36\u201340","journal-title":"Nutr Cancer"},{"key":"3156_CR3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J, et al. (2008) Cachexia: a new definition. Clin Nutr 27:793\u2013799","journal-title":"Clin Nutr"},{"key":"3156_CR4","unstructured":"Japan Cancer Statistics (2012) from Center for Cancer Control and Information Service, National Cancer Center. http:\/\/ganjoho.jp\/professional\/index.html . Accessed 22 July 2015"},{"key":"3156_CR5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","volume":"69","author":"WD DeWys","year":"1980","unstructured":"DeWys WD, Begg C, Lavin PT, et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491\u2013497","journal-title":"Am J Med"},{"key":"3156_CR6","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross PJ, Ashley S, Norton A, et al. (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90:1905\u20131911","journal-title":"Br J Cancer"},{"key":"3156_CR7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jpainsymman.2003.05.003","volume":"26","author":"T Okuyama","year":"2003","unstructured":"Okuyama T, Wang XS, Akechi T, et al. (2003) Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manag 26:1093\u20131104","journal-title":"J Pain Symptom Manag"},{"key":"3156_CR8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1099-1611(199907\/08)8:4<355::AID-PON401>3.0.CO;2-I","volume":"8","author":"M Kurihara","year":"1999","unstructured":"Kurihara M, Shimizu H, Tsuboi K, et al. (1999) Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy. Psychooncology 8:355\u2013363","journal-title":"Psychooncology"},{"key":"3156_CR9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","volume":"104","author":"MJ Proctor","year":"2011","unstructured":"Proctor MJ, Morrison DS, Talwar D, et al. (2011) An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 104:726\u2013734","journal-title":"Br J Cancer"},{"key":"3156_CR10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1207\/s15328007sem1203_2","volume":"12","author":"KH Kim","year":"2005","unstructured":"Kim KH (2005) The relation among fit indexes, power, and sample size in structural equation modeling. Struct Equ Model 12:368\u2013390","journal-title":"Struct Equ Model"},{"key":"3156_CR11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al. (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"3156_CR12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, et al. (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733\u2013742","journal-title":"N Engl J Med"},{"key":"3156_CR13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdu085","volume":"25","author":"M Aapro","year":"2014","unstructured":"Aapro M, Arends J, Bozzetti F, et al. (2014) Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol 25:1492\u20131499","journal-title":"Ann Oncol"},{"key":"3156_CR14","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","volume":"13","author":"CM Prado","year":"2007","unstructured":"Prado CM, Baracos VE, McCargar LJ, et al. (2007) Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13:3264\u20133268","journal-title":"Clin Cancer Res"},{"key":"3156_CR15","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, et al. (2009) Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15:2920\u20132926","journal-title":"Clin Cancer Res"},{"key":"3156_CR16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","volume":"88","author":"GB Stene","year":"2013","unstructured":"Stene GB, Helbostad JL, Balstad TR, et al. (2013) Effect of physical exercise on muscle mass and strength in cancer patients during treatment\u2014a systematic review. Crit Rev Oncol Hematol 88:573\u2013593","journal-title":"Crit Rev Oncol Hematol"},{"key":"3156_CR17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","volume":"16","author":"JM Garcia","year":"2015","unstructured":"Garcia JM, Boccia RV, Graham CD, et al. (2015) Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomized, placebo-controlled, double-blind trials. Lancet Oncol 16:108\u2013116","journal-title":"Lancet Oncol"},{"key":"3156_CR18","doi-asserted-by":"crossref","unstructured":"Temel JS, Currow DC, Fearon K et al (2015) Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2). Abstract 9500. 2015 ASCO Annual Meeting, San Francisco, CA, August 7\u20138, 2015. J Clin Oncol 33 (suppl; abstr 9500)","DOI":"10.1200\/jco.2015.33.15_suppl.9500"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3156-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3156-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:46:08Z","timestamp":1589633168000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3156-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3156"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3156-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]}}}